Position in ASND
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$29,961,800
+$4,565,983 QoQ
Shares Held
130,992
+10.0% QoQ
Ownership
0.200%
of shares outstanding
% of Portfolio
1.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 93.68663735189935.ToString("F0")%
Shared 6.313362648100647.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BRAUN STACEY ASSOCIATES INC holds $41,758,826 across 2 Biotechnology names. ASND ranks #1 (71.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
This page
|
130,992 | $29,961,800 | |
| 2 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
324,808 | $11,797,026 |
All Filings in ASND
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,961,800 | 130,992 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $25,395,817 | 119,095 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $18,677,603 | 93,947 | Shares | Sole | 2025-10-21 | |
| No filing history on record for this holder in this stock. | ||||||